• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过单链构象多态性检测丙型肝炎病毒复杂性及对干扰素治疗的反应

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy.

作者信息

Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, Igimi H, Kamada T, Uchida K

机构信息

Diagnostic Science Department, Shionogi Biomedical Laboratories, Shionogi & Co., Ltd., Osaka, Japan.

出版信息

Gastroenterology. 1995 Mar;108(3):789-95. doi: 10.1016/0016-5085(95)90452-2.

DOI:10.1016/0016-5085(95)90452-2
PMID:7533113
Abstract

BACKGROUND/AIMS: Hepatitis C virus (HCV) genome heterogeneity by sequence analysis in association with interferon (IFN) inefficacy has been reported. This study was performed to establish a convenient method for detecting the HCV quasispecies complexity and to determine the correlation between the complexity and the responsiveness to IFN therapy in patients with chronic hepatitis C.

METHODS

The quasispecies complexity of HCV hypervariable region 1 in patients treated with IFN-alpha was analyzed by polymerase chain reaction-mediated single-strand conformation polymorphism (SSCP).

RESULTS

Seven of 25 patients (28%) with low complexity (SSCP band number of < or = 2) were HCV RNA negative after treatment, whereas in 24 patients with high complexity (SSCP band number of > or = 3), the response to IFN was almost insignificant because only 1 patient (4.5%) remained HCV RNA negative after treatment (P < 0.05). Among type 1b patients, IFN therapy was only effective for patients with low amounts of HCV RNA (< or = 10(7.5) copies/mL serum) and low complexity. In contrast, most type 2a patients tended to respond to the therapy with exceptions being those with high amounts of HCV RNA and high complexity.

CONCLUSIONS

The complexity of the hypervariable region 1 quasispecies may be a factor for predicting IFN inefficacy in patients with chronic hepatitis C.

摘要

背景/目的:已有报道称,通过序列分析发现丙型肝炎病毒(HCV)基因组异质性与干扰素(IFN)治疗无效有关。本研究旨在建立一种便捷的方法来检测HCV准种复杂性,并确定慢性丙型肝炎患者中该复杂性与IFN治疗反应性之间的相关性。

方法

采用聚合酶链反应介导的单链构象多态性(SSCP)分析接受α-干扰素治疗患者的HCV高变区1准种复杂性。

结果

25例复杂性低(SSCP条带数≤2)的患者中,7例(28%)治疗后HCV RNA呈阴性;而在24例复杂性高(SSCP条带数≥3)的患者中,IFN治疗反应几乎不明显,因为治疗后仅1例患者(4.5%)HCV RNA仍为阴性(P<0.05)。在1b型患者中,IFN治疗仅对HCV RNA量低(≤10⁷.⁵拷贝/毫升血清)且复杂性低的患者有效。相比之下,大多数2a型患者倾向于对治疗有反应,但HCV RNA量高且复杂性高的患者除外。

结论

高变区1准种的复杂性可能是预测慢性丙型肝炎患者IFN治疗无效的一个因素。

相似文献

1
Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy.通过单链构象多态性检测丙型肝炎病毒复杂性及对干扰素治疗的反应
Gastroenterology. 1995 Mar;108(3):789-95. doi: 10.1016/0016-5085(95)90452-2.
2
Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.丙型肝炎病毒基因组高变区1与干扰素治疗反应
Clin Chem Lab Med. 2000 Sep;38(9):905-10. doi: 10.1515/CCLM.2000.132.
3
Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.慢性丙型肝炎患者抗病毒治疗期间血清丙型肝炎病毒载量及准种复杂性的动态变化
J Clin Virol. 2001 Jan;20(1-2):85-9. doi: 10.1016/s1386-6532(00)00160-8.
4
Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients.
J Gastroenterol Hepatol. 2001 Apr;16(4):416-23. doi: 10.1046/j.1440-1746.2001.02462.x.
5
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.丙型肝炎病毒(HCV)高变区1(HVR1)的遗传复杂性:对慢性丙型肝炎患者感染特征及干扰素α治疗反应的影响
J Med Virol. 1998 Apr;54(4):256-64.
6
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].慢性丙型肝炎病毒1b基因型感染患者中丙型肝炎病毒基因组复杂性与肝脏疾病严重程度及对干扰素反应的关系[干扰素校正]
Hepatology. 1999 Mar;29(3):897-903. doi: 10.1002/hep.510290306.
7
Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.慢性丙型肝炎病毒感染不同疾病阶段准种的多样性及其在干扰素治疗中的意义。
Hepatology. 1995 Jul;22(1):30-5.
8
[Fluctuation of HCV quasi-species population during interferon therapy; analysis by single strand conformation polymorphism].[干扰素治疗期间丙型肝炎病毒准种群体的波动;单链构象多态性分析]
Nihon Rinsho. 1994 Jul;52(7):1707-15.
9
Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group.
Scand J Gastroenterol. 1996 Oct;31(10):1021-6. doi: 10.3109/00365529609003123.
10
Selection of hepatitis C virus quasispecies during interferon treatment.干扰素治疗期间丙型肝炎病毒准种的选择。
Arch Virol. 1996;141(10):1921-32. doi: 10.1007/BF01718204.

引用本文的文献

1
Advanced molecular surveillance of hepatitis C virus.丙型肝炎病毒的高级分子监测
Viruses. 2015 Mar 13;7(3):1153-88. doi: 10.3390/v7031153.
2
Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.聚乙二醇干扰素联合利巴韦林治疗患者丙型肝炎病毒多聚蛋白位点的共同进化。
J Virol. 2011 Apr;85(7):3649-63. doi: 10.1128/JVI.02197-10. Epub 2011 Jan 19.
3
Evolution of interferon-based therapy for chronic hepatitis C.慢性丙型肝炎基于干扰素治疗的演变
Hepat Res Treat. 2010;2010:140953. doi: 10.1155/2010/140953. Epub 2010 Oct 10.
4
High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.丙型肝炎病毒准种的高度多样性与接受抗病毒治疗患者的早期病毒学应答相关。
Hepatology. 2009 Dec;50(6):1765-72. doi: 10.1002/hep.23290.
5
Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.丙型肝炎病毒的遗传多样性:对抗病毒治疗的影响及相关问题
World J Gastroenterol. 2007 May 7;13(17):2416-26. doi: 10.3748/wjg.v13.i17.2416.
6
Viral determinants of resistance to treatment in patients with hepatitis C.丙型肝炎患者治疗耐药性的病毒决定因素。
Clin Microbiol Rev. 2007 Jan;20(1):23-38. doi: 10.1128/CMR.00010-06.
7
Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C.准种作为慢性丙型肝炎患者抗病毒治疗的预测反应因素
Dig Dis Sci. 2006 May;51(5):960-7. doi: 10.1007/s10620-006-9347-2.
8
Genetic evolution of structural region of hepatitis C virus in primary infection.丙型肝炎病毒初次感染时结构区的基因进化
World J Gastroenterol. 2002 Aug;8(4):686-93. doi: 10.3748/wjg.v8.i4.686.
9
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.丙肝病毒准种在干扰素治疗期间的早期变化可预测治疗结果。
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3081-6. doi: 10.1073/pnas.052712599.
10
Diversity of hepatitis C virus quasispecies evaluated by denaturing gradient gel electrophoresis.通过变性梯度凝胶电泳评估丙型肝炎病毒准种的多样性。
Clin Diagn Lab Immunol. 2001 Jan;8(1):62-73. doi: 10.1128/CDLI.8.1.62-73.2001.